Showing 3651-3660 of 9301 results for "".
- Hemoglobin Discovered in the Epidermishttps://practicaldermatology.com/news/hemoglobin-discovered-in-the-epidermis/2462140/Hemoglobin is present in the epidermis, according to new research that sheds light on the skin's protective properties. For the first time,reesearchers discovered the hemoglobin α protein in human and mouse keratinocytes of the epidermis and in hair follicles. Hemoglobin binds gases such as oxygen…
- Ichthyosis Linked to Mood Disordershttps://practicaldermatology.com/news/ichthyosis-linked-to-mood-disorders/2462139/People living with Ichthyosis may be at higher risk for mental health conditions like depression and anxiety, according to a recent study in the Journal of the American Academy of Dermatology. Researchers at Yale School of Medicine identified 334 patients with congenital ichthyosis from the All Of…
- Ankyra Therapeutics and Regeneron to Evaluate ANK-101 in Combination with Cemiplimab in Patients CSCChttps://practicaldermatology.com/news/ankyra-therapeutics-and-regeneron-to-evaluate-ank-101-in-combination-with-cemiplimab-in-patients-cscc/2462132/Ankyra Therapeutics will be working with Regeneron to evaluate ANK-101 in combination with Regeneron’s anti-PD-1 therapy, Libtayo (cemiplimab) in patients with cutaneous squamous cell carcinoma (CSCC) via a new a clinical trial supply agreement. ANK-101 is a novel first-in-class anchored IL-12 imm…
- ACAAI News: 72% of AD Patients Report Poor Mental Health for 1-10 Days in the Past Monthhttps://practicaldermatology.com/news/acaai-news-72-of-ad-patients-report-poor-mental-health-for-1-10-days-in-the-past-month/2462129/Folks with atopic dermatitis (AD) are more likely to report poor mental health than their counterparts without the inflammatory skin condition, new research shows. The study, which was presented at the 2023 American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting in An…
- Language Barriers Linked to Underdiagnosis of Eczema and Other Allergic Conditionshttps://practicaldermatology.com/news/language-barriers-linked-to-underdiagnosis-of-eczema-and-other-allergic-conditions/2462128/Language barriers may cause some kids with allergic conditions such as eczema, food allergy, and asthma to be underdiagnoses, according to research presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting in Anaheim, CA. “We wondered if those who spoke …
- CeraVe Launches in Indiahttps://practicaldermatology.com/news/cerave-launches-in-india/2462126/L'Oréal Dermatological Beauty recently unveiled CeraVe in India. To support the launch, the brand hosted 'Skin Barrier Science - A Dermatological Summit' in Mumbai, with dermatologists, experts, and partners from all over India and the world to highlight the importance of providing patients with a…
- Updated AAD Guidelines on AD in Adults Back Use of Biologics, JAK Inhibitorshttps://practicaldermatology.com/news/updated-aad-guidelines-on-ad-in-adults-back-use-of-biologics-jak-inhibitors/2462123/Updated American Academy of Dermatology (AAD) guidelines on systemic treatment of atopic dermatitis (AD) in adults strongly back the use of dupilumab, tralokinumab, abrocitinib, baricitinib, and upadacitinib. “When the last guidelines were published in 2014, only non-targeted, off-label systemic m…
- TNF Blockers Are Not Associated With Poor Pregnancy Outcomeshttps://practicaldermatology.com/news/tnf-blockers-are-not-associated-with-poor-pregnancy-outcomes/2462122/Continuing tumor necrosis factor (TNF) inhibitors during pregnancy is not associated with worse fetal or obstetric outcomes and may reduce the risk of severe maternal infections during pregnancy, according to research presented at ACR Convergence 2023, the American College of Rheumatology’s (ACR) …
- In the Lab With Boston University Melanoma Researcher Deborah Langhttps://practicaldermatology.com/news/in-the-lab-with-boston-university-melanoma-researcher-deborah-lang-phd/2462120/Deborah Lang, PhD, associate professor of dermatology at Boston University Chobanian & Avedisian School of Medicine, received a two-year, $300,000 Discovery Boost Grant from the American Cancer Society (ACS) for her research project “Exploring roles for PAX3 in regulating gene expression on a post …
- Ventyx Biosciences Halts Trial for Experimental Psoriasis Drughttps://practicaldermatology.com/news/ventyx-biosciences-halts-trial-for-experimental-psoriasis-drug/2462116/Ventyx Biosciences has announced it is halting development of an experimental psoriasis drug due to missed internal targets required for it to advance beyond Phase 2, according to the company. The drug, VTX958, had shown acceptable safety and efficacy, and had achevied with its 225 mg BID and 300 …